Innovative Research Award
Marina Russo
Luigi Vanvitelli, Italy
| Marina Russo |
| Affiliation |
Luigi Vanvitelli |
| Country |
Italy |
| Scopus ID |
59306460700 |
| Documents |
22 |
| Citations |
116 |
| h-index |
7 |
| Subject Area |
Pharmacology, Toxicology and Pharmaceutical Science |
| Event |
International Award and Honors |
The Innovative Research Award recognizes researchers whose scholarly activities contribute to the advancement of scientific knowledge and the development of innovative approaches within their respective disciplines. Marina Russo of Luigi Vanvitelli, Italy, has established a research profile focused on pharmacology, toxicology, molecular medicine, inflammation biology, and therapeutic innovation. Her publication record reflects sustained contributions to translational biomedical research, particularly in studies exploring inflammatory mechanisms, retinal disorders, metabolic disease complications, and novel therapeutic interventions.[1]
Abstract
Marina Russo’s research portfolio demonstrates active engagement in pharmaceutical sciences and translational biomedical investigations. Her studies address inflammatory pathways, neurovascular complications, diabetic disorders, ocular diseases, and innovative therapeutic strategies. Through interdisciplinary collaborations and peer-reviewed publications, she has contributed to expanding scientific understanding of disease mechanisms and potential pharmacological interventions.[2]
Keywords
Pharmacology, Toxicology, Pharmaceutical Sciences, Inflammation Research, Diabetic Retinopathy, Drug Delivery Systems, Molecular Medicine, Therapeutic Innovation.
Introduction
Scientific innovation in pharmaceutical and biomedical sciences requires a combination of experimental rigor, interdisciplinary collaboration, and translational relevance. Marina Russo has participated in research initiatives investigating inflammatory mediators, retinal degeneration, metabolic disorders, and therapeutic compounds. Her scholarly activities align with contemporary efforts to develop effective treatments for chronic diseases and inflammation-associated conditions.[3]
Research Profile
According to available scholarly metrics, Marina Russo has authored or co-authored 22 indexed publications, receiving 116 citations and attaining an h-index of 7. Her research activities are primarily associated with Pharmacology, Toxicology and Pharmaceutical Science, with emphasis on disease mechanisms, pharmacological modulation, ocular health, and translational medicine.[1]
Research Contributions
- Investigation of lipid mediator biosynthesis inhibitors with potential anti-inflammatory applications.
- Research on Vitamin D3 administration and protection against corneal damage in experimental disease models.
- Exploration of galectin and purinergic receptor inhibition strategies in diabetic retinopathy.
- Studies examining beta-hydroxybutyrate effects on retinal neurobiology and autophagy pathways.
- Development of innovative drug delivery systems targeting diabetic cardiovascular complications.
Publications
- Potenza M, Giordano A, Chini MG, Saviano A, Kretzer C, Raucci F, Russo M, et al. Identification of 2-Aminoacyl-1,3,4-thiadiazoles as Prostaglandin E2 and Leukotriene Biosynthesis Inhibitors. ACS Medicinal Chemistry Letters, 2022.
- Trotta MC et al. Oral Administration of Vitamin D3 Prevents Corneal Damage in a Knock-Out Mouse Model of Sjögren’s Syndrome. Biomedicines, 2023.
- Lepre CC, Russo M et al. Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in Diabetic Retinopathy. IJMS, 2023.
- Trotta MC et al. Systemic Beta-Hydroxybutyrate Affects BDNF and Autophagy in the Retina of Diabetic Mice. IJMS, 2023.
- Trotta MC et al. Chrysin-Based Supramolecular Cyclodextrin-Calixarene Drug Delivery System. Frontiers in Pharmacology, 2023.
Research Impact
The impact of Russo’s research is reflected through scholarly citations, collaborative publications, and contributions to emerging therapeutic approaches. Her work has supported broader scientific discussions concerning inflammatory diseases, ocular pathology, metabolic complications, and pharmaceutical innovation. These contributions strengthen the evidence base for future translational and clinical investigations.[4]
Award Suitability
Marina Russo’s research profile demonstrates characteristics commonly associated with innovative scientific achievement, including interdisciplinary collaboration, publication productivity, and engagement with clinically relevant biomedical challenges. Her contributions to pharmacological research and therapeutic development align with the objectives of the International Award and Honors program, which seeks to recognize meaningful advancements in research and innovation.[5]
Conclusion
Marina Russo has developed a growing academic profile within pharmaceutical sciences through contributions addressing inflammation, diabetic complications, retinal health, and therapeutic innovation. Her publication record, citation performance, and participation in multidisciplinary research initiatives support recognition through the Innovative Research Award and reflect ongoing engagement with contemporary biomedical challenges.
External Links
References
- Elsevier. (n.d.). Scopus author details: Marina Russo, Author ID 59306460700. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=59306460700
- Potenza M et al. (2022). Identification of 2-Aminoacyl-1,3,4-thiadiazoles as Prostaglandin E2 and Leukotriene Biosynthesis Inhibitors. ACS Medicinal Chemistry Letters.
- Trotta MC et al. (2023). Oral Administration of Vitamin D3 Prevents Corneal Damage in a Knock-Out Mouse Model of Sjögren’s Syndrome. Biomedicines.
- Lepre CC, Russo M et al. (2023). Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in Diabetic Retinopathy. International Journal of Molecular Sciences.
- Trotta MC et al. (2023). Systemic Beta-Hydroxybutyrate Affects BDNF and Autophagy in the Retina of Diabetic Mice. International Journal of Molecular Sciences.
- International Award and Honors. (n.d.). Award program information and recognition criteria.
awardandhonors.com